Combined Methyltransferase/Histone deacetylase inhibition with 5Azacitidine and MS-275 in patients with MDS, CMMoL and AML: Clinical response, Histone Acetylation and DNA damage.

被引：18

作者：

Gore, Steven D.

Jiemjit, Anchalee

Silverman, Lewis B.

Aucott, Timothy

Baylin, Stephen

Carraway, Hetty

Douses, Tianna

Fandy, Tamer

Herman, James

Karp, Judith E.

Licht, Jonathan D.

Murgo, Anthony J.

Odchimar-Reissig, Rosalie

Smith, B. Douglas

Zwiebel, James A.

Sugar, Elizabeth

机构：

[1] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[2] Mt Sinai Sch Med, New York, NY USA

[3] Northwestern Univ, Chicago, IL 60611 USA

[4] Natl Canc Inst, Canc Therapy Evaluat Program, Bethesda, MD USA

来源：

关键词：

D O I：

10.1182/blood.V108.11.517.517

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

517

引用

页码：156A / 157A

页数：2